Recent studies have provided valuable insights into the genetic underpinnings of 3M syndrome. For instance, a study involving a cohort of Tunisian patients identified a founder mutation in the ...
Relmada, which has turned to strategic options after scrapping two phase 3 trials in major depressive disorder (MDD), is ...
Relmada Therapeutics has acquired complete worldwide ownership rights to Sepranolone from Sweden-based Asarina Pharma.
This lovely rescue pup has a friendly personality overall. Unfortunately, the condition he's suffering from makes him have ...
PHOTO BY UNSIE ZUEGE Last Friday afternoon, Liberty Davidson’s second grade classmates at Victoria Elementary School planted a tree in her memory. Liberty, 8, who had Down’s Syndrome, ...
Shares of industrial conglomerate 3M (NYSE:MMM) jumped 6.1% in the pre-market session after the company reported fourth-quarter results, which exceeded analysts' revenue and EPS expectations.
Metabolic syndrome is a constellation of conditions that together increase the risk of type 2 diabetes, stroke, and cardiovascular problems, including heart attack. The features of metabolic syndrome ...
Joleen Plekkenpol of Chanhassen woke up one morning with a “flat” foot; something was wrong with the ligaments. And gradually, this loosening of her joints and ligaments moved ...
3M is struggling with anemic growth and major litigation headwinds. Its new CEO is trying to gradually turn around its ailing business. Its stock looks cheap, but it could deserve that discount ...
Richie and Joanie's older brother on Happy Days. His disappearance has become so famous it's become known as the "Chuck ...
3M India Ltd., incorporated in the year 1987, is a Large Cap company (having a market cap of Rs 31,730.60 Crore) operating in Diversified sector. 3M India Ltd. key Products/Revenue Segments include ...
(Reuters) -3M Co forecast profit growth for 2025 and beat fourth-quarter estimates as the U.S. industrial conglomerate benefited from efforts to revive sales and reduce costs, sending its shares ...